Skip to main navigation Skip to search Skip to main content

CT/MRI LI-RADS 2024 Update: Treatment Response Assessment

  • Anum Aslam
  • , Victoria Chernyak
  • , Frank H. Miller
  • , Mustafa Bashir
  • , Richard Do
  • , Claude Sirlin
  • , Robert J. Lewandowski
  • , Charles Y. Kim
  • , Ania Zofia Kielar
  • , Avinash R. Kambadakone
  • , Hooman Yarmohammadi
  • , Edward Kim
  • , Dawn Owen
  • , Resmi A. Charalel
  • , Anuradha Shenoy-Bhangle
  • , Lauren M. Burke
  • , Mishal Mendiratta-Lala

Research output: Contribution to journal › Review article › peer-review

76 Scopus citations

Abstract

With the rising incidence of hepatocellular carcinoma, there has been increasing use of local-regional therapy (LRT) to downstage or bridge totransplant, for definitive treatment, and for palliation. The CT/MRI Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Assessment (TRA) algorithm provides guidance for step-by-step tumor assessment after LRT and standardized reporting. Current evidence suggests that the algorithm performs well in the assessment of tumor response to arterial embolic and loco-ablative therapies and fair when assessing response to radiation-based therapies, with limited data to validate the latter. Both evidence-based and expert-based refinements of the algorithm are needed to improve its diagnostic accuracy after varying types of LRT. This review provides an overview of the challenges and limitations of the LI-RADS TRA algorithm version 2017 and discusses the refinements introduced in the updated 2024 LI-RADS algorithm for CT/MRI.

Original languageEnglish
Article numbere232408
JournalRadiology
Volume313
Issue number2
DOIs
StatePublished - Nov 2024

Fingerprint

Dive into the research topics of 'CT/MRI LI-RADS 2024 Update: Treatment Response Assessment'. Together they form a unique fingerprint.

Cite this